Adjuvant docetaxel and cyclophosphamide (DC) with prophylactic growth colony stimulating factor (GCSF) on days 8 and 12 in breast cancer patients: A retrospective analysis.

Authors

null

Rinat Yerushalmi

Institute of Oncology, Davidoff Center, Rabin Medi

Rinat Yerushalmi , Salomon Stemmer , Daniel Hendler , Victoria Neiman , Noa Ciuraru , Luisa Bonilla , Irit Ben-Aharon , Limor Amit , Tal Granot , Alona Zer , Aaron Sulkes , Shulamith Rizel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 Breast Cancer Symposium

Session Type

Poster Session

Session Title

General Poster Session A

Track

Risk Assessment, Prevention, Detection, and Screening

Sub Track

Management of Node-Positive Disease

Citation

J Clin Oncol 30, 2012 (suppl 27; abstr 202)

DOI

10.1200/jco.2012.30.27_suppl.202

Abstract #

202

Poster Bd #

E11

Abstract Disclosures